Author details

Full Name

Chaitanya Bandlamudi

Affiliation

ORCID

Career Start Year

2013

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37864521	Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.	Cancer	2024
37886874	Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.	Cancer	2024
37097610	Clinicopathologic, Genomic, and Immunophenotypic Landscape of ATM Mutations in Non-Small Cell Lung Cancer.	Clin Cancer Res	2023
36346689	NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.	Clin Cancer Res	2023
37845474	Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade.	Nat Med	2023
37738546	Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.	JCO Precis Oncol	2023
37561983	Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.	JCO Precis Oncol	2023
36593350	Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.	NPJ Precis Oncol	2023
37432985	Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.	Clin Cancer Res	2023
36529447	Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations.	Ann Oncol	2023
34810208	Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations.	Cancer Epidemiol Biomarkers Prev	2022
36048199	Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.	Cancer Discov	2022
36041233	Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.	Cancer	2022
36040493	Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice.	Clinical Cancer Research	2022
35833951	Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer.	Clin Cancer Res	2022
35641605	Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness.	Nature	2022
35679859	Impaired humoral immunity is associated with prolonged COVID-19 despite robust CD8 TÂ cell responses.	Cancer Cell	2022
35484264	Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA.	Nat Med	2022
35545680	Fundamental immune-oncogenicity trade-offs define driver mutationÂ fitness.	Nature	2022
35477182	Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.	Cancer Epidemiol Biomarkers Prev	2022
36418296	Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.	Nat Commun	2022
35978189	Ordered and deterministic cancer genome evolution after p53 loss.	Nature	2022
34405229	A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.	J Natl Cancer Inst	2021
34090768	Erratum to 'Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group': [Annals of Oncology 30 (2019) 1221-1231].	Ann Oncol	2021
34250384	Prevalence and Characterization of Biallelic and Monoallelic <i>NTHL1</i> and <i>MSH3</i> Variant Carriers From a Pan-Cancer Patient Population.	JCO Precis Oncol	2021
34351646	Pancreas cancer and BRCA: A critical subset of patients with improving therapeutic outcomes.	Cancer	2021
33199492	Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer.	Clin Cancer Res	2021
34741162	The context-specific role of germline pathogenicity in tumorigenesis.	Nat Genet	2021
32561401	COVID-19 in patients with lung cancer.	Ann Oncol	2020
31794323	Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.	J Clin Oncol	2020
32178965	Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas.	Ann Oncol	2020
32299819	Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing.	Clin Cancer Res	2020
32396853	Bridging the Gap: The Impact of Genetic Ancestry on Routes to Tumorigenesis.	Cancer Cell	2020
32393777	Protein-altering germline mutations implicate novel genes related to lung cancer development.	Nat Commun	2020
32461694	Phase and context shape the function of composite oncogenic mutations.	Nature	2020
32709715	The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer.	Clin Cancer Res	2020
32816945	HLA Genotyping in Synovial Sarcoma: Identifying HLA-A*02 and Its Association with Clinical Outcome.	Clin Cancer Res	2020
30620386	Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.	Cancer	2019
30376427	Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.	J Clin Oncol	2019
30013179	Genome doubling shapes the evolution and prognosis of advanced cancers.	Nat Genet	2018
30068706	Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer.	Clin Cancer Res	2018
30205045	The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.	Cancer Cell	2018
28263985	Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.	PLoS Genet	2017
24464852	Bionimbus: a cloud for managing, analyzing and sharing large genomics datasets.	J Am Med Inform Assoc	2014
23212519	CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.	Blood	2013